Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care giúp cho các bạn có thêm kiến thức về ngành y học đề tài: First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy. | Clinical and Molecular Allergy BioMed Central Case Report Open Access First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy Eric Scott Sills Susan C Conway Carolyn R Kaplan Mark Perloe and Michael J Tucker Address Georgia Reproductive Specialists Division of Reproductive Endocrinology and Infertility Department of Obstetrics and Gynecology Atlanta Medical Center Atlanta Georgia USA Email Eric Scott Sills - Susan C Conway - sconway@ Carolyn R Kaplan - ckaplan@ Mark Perloe - mperloe@ Michael J Tucker - mtucker@ Corresponding author Published 19 October 2004 Received 18 August 2004 Accepted 19 October 2004 Clinical and Molecular Allergy 2004 2 1 I doi 1476-7961-2-11 H This article is available from http content 2 1 11 2004 Sills et al licensee BioMed Central Ltd. This is an open-access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background To describe immune and endocrine responses in severe hymenoptera hypersensitivity requiring venom immunotherapy VIT during in vitro fertilization IVF . Case presentation A 39-year old patient was referred for history of multiple miscarriage and a history of insect sting allergy. Four years earlier she began subcutaneous injection of 100 mcg mixed vespid hymenoptera venom venom protein every 5-6 weeks. The patient had one livebirth and three first trimester miscarriages. Allergy treatment was maintained for all pregnancies ending in miscarriage although allergy therapy was discontinued for the pregnancy that resulted in delivery. At our institution ovulation induction incorporated venom immunotherapy VIT during IVF with a reduced VIT dose when pregnancy was first identified. Serum .
